These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15777574)

  • 1. Management of cirrhosis due to chronic hepatitis C.
    Everson GT
    J Hepatol; 2005; 42 Suppl(1):S65-74. PubMed ID: 15777574
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiviral therapy in HCV decompensated cirrhosis: to treat or not to treat?
    Navasa M; Forns X
    J Hepatol; 2007 Feb; 46(2):185-8. PubMed ID: 17161494
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of chronic hepatitis C virus infection: we must target the virus or liver fibrosis?
    Soriano V; Martín-Carbonero L; García-Samaniego J
    AIDS; 2003 Mar; 17(5):751-3. PubMed ID: 12646800
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chronic hepatitis C. Treatment of special groups].
    Civeira MP
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():68-70. PubMed ID: 11968348
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term effects of sustained virologic response on the development of esophageal varices in compensated cirrhosis: "is the bang worth the buck?".
    Sterling RK
    Hepatology; 2010 Jun; 51(6):1891-3. PubMed ID: 20512983
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of HCV infection in patients with advanced cirrhosis.
    Forns X; Navasa M; Rodés J
    Hepatology; 2004 Aug; 40(2):498. PubMed ID: 15368458
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to Soriano et al., 'Treatment of chronic hepatitis C virus infection: we must target the virus or liver fibrosis?'.
    Matthews G; Dore G
    AIDS; 2003 Dec; 17(18):2675-6. PubMed ID: 14685063
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis C. An update.
    Bren L
    FDA Consum; 2001; 35(4):24-9. PubMed ID: 11692881
    [No Abstract]   [Full Text] [Related]  

  • 9. Sustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1,386-patient study from Taiwan.
    Huang JF; Yu ML; Lee CM; Dai CY; Hou NJ; Hsieh MY; Wang JH; Lu SN; Sheen IS; Lin SM; Chuang WL; Liaw YF
    Aliment Pharmacol Ther; 2007 May; 25(9):1029-37. PubMed ID: 17439503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of patients with hepatitis B virus-induced cirrhosis.
    Fung SK; Lok AS
    J Hepatol; 2005; 42 Suppl(1):S54-64. PubMed ID: 15777573
    [No Abstract]   [Full Text] [Related]  

  • 11. Hormones: a potential explanation for differences in response rates to therapy for chronic hepatitis C infection.
    Forde KA; Reddy KR
    Gastroenterology; 2011 Mar; 140(3):776-9. PubMed ID: 21262187
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of host insulin resistance on fibrosis and response to interferon in chronic hepatitis C.
    Moţa M; Popa S; Mota E; Diaconescu I; Gheorghiţoiu I; Panduru M
    Rom J Intern Med; 2008; 46(2):105-12. PubMed ID: 19284081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hepatitis C in patients who have decompensated cirrhosis.
    Everson GT
    Clin Liver Dis; 2005 Aug; 9(3):473-86, viii. PubMed ID: 16023978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of chronic hepatitis C.
    Asselah T; Boyer N; Ripault MP; Martinot M; Marcellin P
    Minerva Gastroenterol Dietol; 2007 Mar; 53(1):9-23. PubMed ID: 17415342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spectrum of hepatic functional impairment in compensated chronic hepatitis C: results from the Hepatitis C Anti-viral Long-term Treatment against Cirrhosis Trial.
    Everson GT; Shiffman ML; Morgan TR; Hoefs JC; Sterling RK; Wagner DA; Kulig CC; Curto TM; Wright EC;
    Aliment Pharmacol Ther; 2008 May; 27(9):798-809. PubMed ID: 18266997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The irreversibility of cirrhosis: "the jostle dogma"].
    Fartoux L; Pol S; Serfaty L
    Rev Prat; 2005 Sep; 55(14):1549-51. PubMed ID: 16255296
    [No Abstract]   [Full Text] [Related]  

  • 18. Review article: predicting response in hepatitis C virus therapy.
    Mihm U; Herrmann E; Sarrazin C; Zeuzem S
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1043-54. PubMed ID: 16611264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver steatosis and antiviral therapy in chronic hepatitis C.
    Testino G; Sumberaz A
    Liver Int; 2007 Mar; 27(2):287. PubMed ID: 17311627
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic hepatitis C in the human immunodeficiency virus-infected patient: management strategies.
    Bhattacharya D; Imperial JC; Keeffe EB
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):288-92. PubMed ID: 16527689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.